563
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Five days serum glucose stability at room-temperature in centrifuged fast-clotting serum tubes and the comparability with glucose in heparin-plasma and plasma containing citrate-stabilizer

, , &
Pages 62-67 | Received 21 Jun 2023, Accepted 10 Feb 2024, Published online: 07 Mar 2024

References

  • Diagnostic criteria and classification of hyperglycemia first detected in pregnancy: a World Health Organization Guideline. Diabetes Res Clin Pract. 2014;103(3):341–363.
  • Sacks DB, Arnold M, Bakris GL, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2023;69(8):808–868. doi: 10.1093/clinchem/hvad080.
  • Chan AY, Swaminathan R, Cockram CS. Effectiveness of sodium fluoride as a preservative of glucose in blood. Clin Chem. 1989;35(2):315–317. doi: 10.1093/clinchem/35.2.315.
  • World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva, Switzerland: WHO; 2006.
  • Carey R, Lunt H, Heenan HF, et al. Collection tubes containing citrate stabiliser over-estimate plasma glucose, when compared to other samples undergoing immediate plasma separation. Clin Biochem. 2016;49(18):1406–1411. doi: 10.1016/j.clinbiochem.2016.05.017.
  • Saracevic A, Dukic L, Juricic G, et al. Various glycolysis inhibitor-containing tubes for glucose measurement cannot be used interchangeably due to clinically unacceptable biases between them. Clin Chem Lab Med. 2018;56(2):236–241. doi: 10.1515/cclm-2017-0279.
  • Orth M, Hawran H, Ulloor J, et al. Effects of different tube types on patient classification using current diabetes decision limits. Pract Lab Med. 2019;17:e00134. doi: 10.1016/j.plabm.2019.e00134.
  • Song D, Lia M, Hurley JC. Recommended pre-analytical plasma glucose sampling methodology may distort gestational diabetes mellitus prevalence: implications for diagnostic thresholds. Diabet Med. 2019;36(10):1226–1233. doi: 10.1111/dme.14073.
  • Szoke D, Borille S, Cardellicchio M, et al. Impact of optimizing pre-analytical phase on the diagnosis of gestational diabetes and related outcomes. Clin Chem Lab Med. 2021;59(12):1981–1987. doi: 10.1515/cclm-2021-0706.
  • Juricic G, Kopcinovic LM, Saracevic A, et al. Liquid citrate acidification introduces significant glucose bias and leads to misclassification of patients with diabetes. Clin Chem Lab Med. 2016;54(2):363–371.
  • van den Berg SAA, Thelen MHM, Salden LPW, et al. It takes acid, rather than ice, to freeze glucose. Sci Rep. 2015;5(1):8875. doi: 10.1038/srep08875.
  • Winter T, Hannemann A, Suchsland J, et al. Long-terms stability of glucose: glycolysis inhibitor vs. gel barrier tubes. Clin Chem Lab Med. 2018;56(8):1251–1258. doi: 10.1515/cclm-2017-0860.
  • Winter T, Greise A, Nauck M, et al. Long-terms stability of glucose: 96-h study using terumo glycaemia tubes. Clin Chem Lab Med. 2016;54(3):407–410.
  • Yan R, Lou A, Watts G, et al. Comparison of Becton Dickinson vacutainer rapid serum tube with serum separator tube for routine chemistry and immunoassay tests. J Clin Pathol. 2014;67(7):599–604. doi: 10.1136/jclinpath-2013-202130.
  • Dimeski G, Johnston J, Masci PP, et al. Evaluation of the Greiner Bio-One serum separator BCA fast clot tube. Clin Chem Lab Med. 2017;55(8):1135–1141. doi: 10.1515/cclm-2016-0806.
  • Cornes M, Simundic AM, Cadamuro J, et al. The CRESS checklist for reporting stability studies: on behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-Pre). Clin Chem Lab Med. 2021;59(1):59–69. doi: 10.1515/cclm-2020-0061.
  • Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015–2038. doi: 10.1515/cclm-2018-0602.
  • Sandberg S, Fraser CG, Horvath AR, et al. Defining analytical performance specifications: consensus statement from the 1st strategic conference of the European Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem Lab Med. 2015;53(6):833–835.
  • Aarsand AK, Fernandez-Calle P, Webster C, et al. The EFLM Biological Variation Database; 2021 [cited 2021 Mar 2]. Available from: http://biologicalvariation.eu/
  • Del Pino IG, Constanso I, Mourìn LV, et al. Citric/citrate buffer: an effective antiglycolytic agent. Clin Chem Lab Med. 2013;51(10):1943–1949. doi: 10.1515/cclm-2012-0735.
  • Bonetti G, Cancelli V, Coccoli G, et al. Which sample tube should be used for routine glucose determination? Prim Care Diabetes. 2016;10(3):227–232. doi: 10.1016/j.pcd.2015.11.003.
  • van der Hagen EAE, Fokkert MJ, Kleefman AMD, et al. Technical and clinical validation of the Greiner FC-Mix glycaemia tube. Clin Chem Lab Med. 2017;55(10):1530–1536.
  • Stahl M, Joergensen LGM, Petersen PH, et al. Optimization of preanalytical conditions and analysis of plasma glucose. 1. Impact of the new WHO and ADA recommendations on diagnosis of diabetes mellitus. Scand J Clin Lab Invest. 2001;61(3):169–180.
  • Sandberg S, Carobene A, Bartlett B, et al. Biological variation: recent development and future challenges. Clin Chem Lab Med. 2023;61(5):741–750. doi: 10.1515/cclm-2022-1255.
  • Gómez Rioja R, Martínez Espartosa D, Segovia M, et al. Laboratory sample stability. Is it possible to define a consensus stability function? An example of five blood magnitudes. Clin Chem Lab Med. 2018;56(11):1806–1818. doi: 10.1515/cclm-2017-1189.